European Companies Search Engine

Managing Director: Hans H. Münchmeyer · Change of legal form: Mulligan BioCapital AG · Capital: €1,000,000 · Share­holder agreement · Legal form: AG · Proxy · Corporate Purpose Hrb30 Nov 2007 German Trade Register Announcements, Germany (29/11/2007)

Overview

Text

Mulligan BioCapital GmbH, Hamburg (Ungenannte Str. ??, 20459 Hamburg, Germany). GmbH. The aim is to broker transactions, with the exception of transactions subject to authorisation, to manage own assets, to establish, to acquire, to participate in and to sell and to sell companies or parts thereof, in particular in the field of biotechnology, and to take over the administration or management, including the appointment as a personally liable partner. Share capital: EUR 1,000,000.00. General representation scheme: If only one managing director is appointed, he shall represent the company alone. If several directors are appointed, the company is represented by two directors or by a managing director together with an authorized representative. The power of sole representation may be granted. Managing directors may be authorised to carry out legal transactions on behalf of the company with themselves in their own name or as a representative of a third party. Managing Director: Münchmeyer, Hans Hermann, Hamburg, *??.??.????, authorized to represent one person; with the power to enter into legal transactions on behalf of the company in its own name or as a representative of a third party. Created by conversion by means of the change of form of the Mulligan BioCapital AG, Hamburg (District Court of Hamburg HRB 78402) in accordance with the resolution of the Annual General Meeting of November 2, 2007.

This filing was translated from German to English. The filing refers to a past date, and does not necessarily reflect the current state. The current state is available on the following page: Mulligan BioCapital GmbH, Bielefeld, Germany.

Creative Commons License The visualizations for "Mulligan BioCapital GmbH - Managing Director: Hans H. Münchmeyer · Change of legal form: Mulligan BioCapital AG · Capital: €1,000,000 · Share­holder agreement · Legal form: AG · Proxy · Corporate Purpose" are provided by North Data and may be reused under the terms of the Creative Commons CC-BY license.